Style | Citing Format |
---|---|
MLA | Khodakarami R, et al.. "Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys." BMC Public Health, vol. 22, no. 1, 2022, pp. -. |
APA | Khodakarami R, Abdi Z, Ahmadnezhad E, Sheidaei A, Asadilari M (2022). Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys. BMC Public Health, 22(1), -. |
Chicago | Khodakarami R, Abdi Z, Ahmadnezhad E, Sheidaei A, Asadilari M. "Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys." BMC Public Health 22, no. 1 (2022): -. |
Harvard | Khodakarami R et al. (2022) 'Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys', BMC Public Health, 22(1), pp. -. |
Vancouver | Khodakarami R, Abdi Z, Ahmadnezhad E, Sheidaei A, Asadilari M. Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys. BMC Public Health. 2022;22(1):-. |
BibTex | @article{ author = {Khodakarami R and Abdi Z and Ahmadnezhad E and Sheidaei A and Asadilari M}, title = {Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys}, journal = {BMC Public Health}, volume = {22}, number = {1}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Khodakarami R AU - Abdi Z AU - Ahmadnezhad E AU - Sheidaei A AU - Asadilari M TI - Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys JO - BMC Public Health VL - 22 IS - 1 SP - EP - PY - 2022 ER - |